Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Molex (Nasdaq: MOLX ) is expected to report Q4 earnings on Aug. 8. Here's what Wall Street wants to see.
The 10-second takeaway
Comparing the upcoming quarter with the prior-year quarter, average analyst estimates predict Molex's revenues will contract -3.8% and EPS will drop -15.6%.
The average estimate for revenue is $878.8 million. On the bottom line, the average EPS estimate is $0.38.
Last quarter, Molex chalked up revenue of $837.1 million. GAAP reported sales were 4.3% lower than the prior-year quarter's $874.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.34. GAAP EPS of $0.36 for Q3 were 7.7% lower than the prior-year quarter's $0.39 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 30.5%, 70 basis points better than the prior-year quarter. Operating margin was 10.9%, 70 basis points worse than the prior-year quarter. Net margin was 7.8%, about the same as the prior-year quarter.
The full year's average estimate for revenue is $3.51 billion. The average EPS estimate is $1.58.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 135 members out of 150 rating the stock outperform, and 15 members rating it underperform. Among 45 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 43 give Molex a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molex is hold, with an average price target of $27.45.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Molex. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Get instant access to this free report.
- Add Molex to My Watchlist.